IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, offering promising developments across various health care and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, additional trusted substitute for therapeutic use,